Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergy immunotherapy for primary care physicians.

Jeffrey R Stokes1, Thomas B Casale

  • 1Creighton University, Division of Allergy/Immunology, Department of Medicine, Omaha, Neb 68131, USA. jstokes@creighton.edu

The American Journal of Medicine
|September 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations.

Allergy·2026
Same author

The monoclonals: What have we learned and where are we going?

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Pragmatic Strategies for Reducing Variability and Risk in Food Oral Immunotherapy.

Clinical reviews in allergy & immunology·2026
Same author

Pirfenidone and its Derivative: Novel Bronchodilators and Leukocyte Airway Inflammation Inhibitors.

American journal of respiratory cell and molecular biology·2026
Same author

No evidence of a differential treatment effect with omalizumab versus placebo across baseline IgE level and BMI subgroups in patients with chronic spontaneous urticaria.

The journal of allergy and clinical immunology. In practice·2026
Same author

Dupilumab in Patients With Chronic Spontaneous Urticaria: Phase 3 LIBERTY-CSU CUPID Randomized Clinical Trials.

JAMA dermatology·2026

Allergen immunotherapy offers long-lasting relief for allergic rhinitis, asthma, and venom hypersensitivity. This treatment involves a build-up phase to a maintenance dose, requiring physician supervision due to potential systemic reactions.

Area of Science:

  • Immunology
  • Allergy and Immunology

Background:

  • Allergic diseases are prevalent, impacting a significant portion of the US population.
  • While pharmacologic treatments exist, allergen-specific immunotherapy (AIT) is unique in its long-lasting therapeutic and immunomodulatory effects.

Purpose of the Study:

  • To highlight the significant and enduring benefits of allergen immunotherapy in managing allergic conditions.
  • To describe the process and safety considerations of allergen immunotherapy.

Main Methods:

  • The abstract describes allergen immunotherapy as a treatment involving a dose escalation (build-up) phase to reach a therapeutic maintenance level.
  • This maintenance level is sustained for 3-5 years.

Main Results:

  • Allergen immunotherapy demonstrates significant and long-lasting therapeutic and immunomodulatory effects.

Related Experiment Videos

  • Most patients tolerate immunotherapy well, though local reactions can occur.
  • Systemic anaphylactic reactions are possible, necessitating administration in a physician's office.

    • Conclusions:

    • Allergen immunotherapy remains a crucial treatment modality for allergic rhinitis, allergic asthma, and venom hypersensitivity.
    • Despite emerging therapies, AIT's established efficacy ensures its continued importance in allergy management.